JPS58144319A - 記憶力増強剤 - Google Patents
記憶力増強剤Info
- Publication number
- JPS58144319A JPS58144319A JP2455182A JP2455182A JPS58144319A JP S58144319 A JPS58144319 A JP S58144319A JP 2455182 A JP2455182 A JP 2455182A JP 2455182 A JP2455182 A JP 2455182A JP S58144319 A JPS58144319 A JP S58144319A
- Authority
- JP
- Japan
- Prior art keywords
- lower alkyl
- memory
- enhancer
- compound
- observed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003623 enhancer Substances 0.000 title abstract 4
- 150000001875 compounds Chemical class 0.000 claims abstract description 15
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 9
- 239000004480 active ingredient Substances 0.000 claims abstract description 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 5
- 239000003695 memory enhancer Substances 0.000 claims description 3
- 125000003545 alkoxy group Chemical group 0.000 claims description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 2
- 125000005504 styryl group Chemical group 0.000 claims description 2
- 230000001747 exhibiting effect Effects 0.000 claims 1
- 230000002496 gastric effect Effects 0.000 claims 1
- 125000005843 halogen group Chemical group 0.000 claims 1
- 238000006467 substitution reaction Methods 0.000 claims 1
- 239000003814 drug Substances 0.000 abstract description 9
- 229940079593 drug Drugs 0.000 abstract description 9
- 210000003169 central nervous system Anatomy 0.000 abstract description 5
- RVSGRNKUJJUAPV-UHFFFAOYSA-N benzo[d][1,2]benzoxazepine Chemical class O1N=CC2=CC=CC=C2C2=CC=CC=C12 RVSGRNKUJJUAPV-UHFFFAOYSA-N 0.000 abstract description 3
- 235000000346 sugar Nutrition 0.000 abstract description 3
- 206010012289 Dementia Diseases 0.000 abstract description 2
- 238000010171 animal model Methods 0.000 abstract description 2
- 230000001430 anti-depressive effect Effects 0.000 abstract description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 2
- 230000002401 inhibitory effect Effects 0.000 abstract description 2
- 230000007246 mechanism Effects 0.000 abstract description 2
- 208000010110 spontaneous platelet aggregation Diseases 0.000 abstract description 2
- 150000002632 lipids Chemical class 0.000 abstract 2
- 241001289721 Lethe Species 0.000 abstract 1
- 239000000935 antidepressant agent Substances 0.000 abstract 1
- 229940005513 antidepressants Drugs 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000001772 blood platelet Anatomy 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 230000003933 intellectual function Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 14
- 241001465754 Metazoa Species 0.000 description 11
- 241000699670 Mus sp. Species 0.000 description 8
- 241000700159 Rattus Species 0.000 description 6
- 239000002775 capsule Substances 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 5
- 239000003826 tablet Substances 0.000 description 5
- 235000013305 food Nutrition 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 229920002261 Corn starch Chemical class 0.000 description 3
- 108010010803 Gelatin Proteins 0.000 description 3
- 230000036760 body temperature Effects 0.000 description 3
- 239000001913 cellulose Chemical class 0.000 description 3
- 229920002678 cellulose Chemical class 0.000 description 3
- 239000008120 corn starch Chemical class 0.000 description 3
- 229920000159 gelatin Polymers 0.000 description 3
- 239000008273 gelatin Substances 0.000 description 3
- 235000019322 gelatine Nutrition 0.000 description 3
- 235000011852 gelatine desserts Nutrition 0.000 description 3
- 229960004801 imipramine Drugs 0.000 description 3
- BCGWQEUPMDMJNV-UHFFFAOYSA-N imipramine Chemical compound C1CC2=CC=CC=C2N(CCCN(C)C)C2=CC=CC=C21 BCGWQEUPMDMJNV-UHFFFAOYSA-N 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- DNXIKVLOVZVMQF-UHFFFAOYSA-N (3beta,16beta,17alpha,18beta,20alpha)-17-hydroxy-11-methoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]-yohimban-16-carboxylic acid, methyl ester Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(C(=O)OC)C(O)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 DNXIKVLOVZVMQF-UHFFFAOYSA-N 0.000 description 2
- 241000272201 Columbiformes Species 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- LCQMZZCPPSWADO-UHFFFAOYSA-N Reserpilin Natural products COC(=O)C1COCC2CN3CCc4c([nH]c5cc(OC)c(OC)cc45)C3CC12 LCQMZZCPPSWADO-UHFFFAOYSA-N 0.000 description 2
- QEVHRUUCFGRFIF-SFWBKIHZSA-N Reserpine Natural products O=C(OC)[C@@H]1[C@H](OC)[C@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)C[C@H]2[C@@H]1C[C@H]1N(C2)CCc2c3c([nH]c12)cc(OC)cc3 QEVHRUUCFGRFIF-SFWBKIHZSA-N 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 239000012752 auxiliary agent Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 235000013312 flour Nutrition 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920001592 potato starch Chemical class 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000013102 re-test Methods 0.000 description 2
- BJOIZNZVOZKDIG-MDEJGZGSSA-N reserpine Chemical compound O([C@H]1[C@@H]([C@H]([C@H]2C[C@@H]3C4=C([C]5C=CC(OC)=CC5=N4)CCN3C[C@H]2C1)C(=O)OC)OC)C(=O)C1=CC(OC)=C(OC)C(OC)=C1 BJOIZNZVOZKDIG-MDEJGZGSSA-N 0.000 description 2
- 229960003147 reserpine Drugs 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- MDMGHDFNKNZPAU-UHFFFAOYSA-N roserpine Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(OC(C)=O)C(OC)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 MDMGHDFNKNZPAU-UHFFFAOYSA-N 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- 208000000044 Amnesia Diseases 0.000 description 1
- 208000031091 Amnestic disease Diseases 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical class OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical class OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 206010017577 Gait disturbance Diseases 0.000 description 1
- 206010060891 General symptom Diseases 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 206010023644 Lacrimation increased Diseases 0.000 description 1
- 229930195725 Mannitol Chemical class 0.000 description 1
- 229920000715 Mucilage Polymers 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920000297 Rayon Polymers 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 239000004902 Softening Agent Substances 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000006986 amnesia Effects 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000000891 anti-reserpine Effects 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 210000003323 beak Anatomy 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229940105329 carboxymethylcellulose Drugs 0.000 description 1
- 229940084030 carboxymethylcellulose calcium Drugs 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 238000004898 kneading Methods 0.000 description 1
- 230000004317 lacrimation Effects 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 239000000594 mannitol Chemical class 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 239000002964 rayon Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 230000028527 righting reflex Effects 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 230000009154 spontaneous behavior Effects 0.000 description 1
- 208000026841 staggering gait Diseases 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 239000007940 sugar coated tablet Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
Landscapes
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2455182A JPS58144319A (ja) | 1982-02-19 | 1982-02-19 | 記憶力増強剤 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2455182A JPS58144319A (ja) | 1982-02-19 | 1982-02-19 | 記憶力増強剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS58144319A true JPS58144319A (ja) | 1983-08-27 |
| JPH0354085B2 JPH0354085B2 (show.php) | 1991-08-19 |
Family
ID=12141282
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2455182A Granted JPS58144319A (ja) | 1982-02-19 | 1982-02-19 | 記憶力増強剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS58144319A (show.php) |
-
1982
- 1982-02-19 JP JP2455182A patent/JPS58144319A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0354085B2 (show.php) | 1991-08-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Huff et al. | Ochratoxicosis in the broiler chicken | |
| DK170922B1 (da) | Cefaclorformulering med langvarig virkning | |
| White et al. | Plasma concentrations of digoxin after oral administration in the fasting and postprandial state | |
| US4393071A (en) | Method of treating gastric, mammary, lung and uterus tumors | |
| HU230771B1 (hu) | Késleltetett leadású vitaminkészítmény | |
| US4847281A (en) | Method of medical treatment of addiction | |
| US20130225559A1 (en) | S-mirtazapine for the treatment of hot flush | |
| KR102388769B1 (ko) | 산조인 분말 및 영실 분말을 포함하는 수면 장애의 예방 또는 개선용 조성물 | |
| JP2011504921A (ja) | メタボリック症候群に作用する組成物の調製における植物エクジソンの使用 | |
| JPS58144319A (ja) | 記憶力増強剤 | |
| EP0521057A1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING IPRIFLAVONE, PROCESS FOR THE PREPARATION AND PHARMACEUTICAL USES OF THESE COMPOSITIONS. | |
| KR20210042042A (ko) | 페놀라민 g형 결정, 제조 방법과 그의 조성물 및 용도 | |
| US4067983A (en) | Pharmaceutical compositions and methods | |
| JP4601069B2 (ja) | 高脂血症治療のための相乗効果的医薬組成物 | |
| DE60309582T2 (de) | Verfahren zur herstellung einer einen antiretroviralen proteasehemmer enthaltenden pharmazeutischen zusammensetzung mit verbesserter bioverfügbarkeit | |
| WO2022137265A1 (en) | Enteric coated hpmc based herbal oil capsule for treatment of irritable bowel syndrome | |
| JPH0434524B2 (show.php) | ||
| RU2274400C1 (ru) | Биологически активная добавка для снижения алкогольной зависимости на основе расторопши пятнистой | |
| Prasad | Phytochemial investigation and evaluation of antiemetic & anthelmintic activities of Polygonum lapathifolium roots | |
| DE2005255C3 (de) | Verwendung von Ca-5-butylpicolinat und/oder Ca-5-pentylpicolinat zur Herstellung eines blutdrucksenkenden Arzneimittels | |
| Bulbul et al. | Phytochemial investigation and evaluation of antiemetic & anthelmintic activities of Polygonum lapathifolium roots extract. | |
| JPS60260520A (ja) | 医薬組成物 | |
| US3053731A (en) | Therapeutic composition containing 4, 6-dimethyl-3-pyridazone and process of inducing hypnosis and tranquilization therewith | |
| JP2002187845A (ja) | タラの芽系抗肥満症剤の製法 | |
| JPS5888313A (ja) | 抗コクシジウム剤 |